Novel Epidemiological Approaches in Clinical Pharmacology and Toxicology
This special issue belongs to the section "Pharmacology".
Special Issue Information
Dear Colleagues,
Novel epidemiological approaches in clinical pharmacology and toxicology aim to enhance our understanding of how drugs affect populations and individuals. These approaches utilize advanced methodologies, data sources, and analytical techniques to investigate the safety, efficacy, and toxicity of drugs. Some of the emerging trends and approaches in this field are represented by real-world data (RWD) and real-world evidence (RWE), Bayesian methods, network pharmacology, longitudinal data analysis, and machine learning and artificial intelligence (AI).
In recent years, novel epidemiological approaches have had a broad and far-reaching impact on clinical pharmacology, toxicology, epidemiology, and other fields.
We have launched a Special Issue, “Novel Epidemiological Approaches in Clinical Pharmacology and Toxicology”, and we encourage you and your colleagues to submit articles related to clinical pharmacology, toxicology, and epidemiology with a focus on new research methodologies. Original research articles and reviews are welcome.
Dr. Niccolò Lombardi
Dr. Giada Crescioli
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- clinical pharmacology
- toxicology
- epidemiology
- the value of real-world evidence
- adverse drug reactions
- drug safety
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Published Papers
J. Clin. Med. - ISSN 2077-0383